Bill

Bill > HB3957


IL HB3957

IL HB3957
GENERIC DRUG PRICING FAIRNESS


summary

Introduced
02/17/2023
In Committee
05/16/2023
Crossed Over
05/03/2023
Passed
05/19/2023
Dead
Signed/Enacted/Adopted
07/28/2023

Introduced Session

103rd General Assembly

Bill Summary

Reinserts the provisions of the introduced bill with the following changes. Sets forth legislative findings. Provides that the Director of Healthcare and Family Services or Director of Central Management Services shall (rather than may) notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the State’s Medical Assistance Program or a State health plan, respectively, that amounts to price gouging. Provides that a notice sent by the Attorney General to the manufacturer or wholesale drug distributor of an essential off-patent or generic drug shall serve as a litigation hold regarding documents and communications about that drug. Provides that upon petition of the Attorney General, a circuit court may issue an order imposing a civil penalty of up to $10,000 per day (rather than only $10,000) for each violation of the Act or providing for the Attorney General's recovery of costs and disbursements incurred in bringing an action against a manufacturer found to be in violation of the Act. Makes other changes. Effective January 1, 2024.

AI Summary

This bill, the Pharmaceutical and Health Affordability: Restrictions on Manufacturers' Amoral Behavior through Reasonable Oversight Act, aims to address the issue of price gouging in the sale of essential off-patent or generic drugs in Illinois. The bill defines "price gouging" as an unconscionable increase in the wholesale acquisition cost of these drugs, and prohibits manufacturers and wholesale drug distributors from engaging in such practices. The Attorney General is empowered to investigate potential violations and seek remedies, including fines, injunctions, and requiring manufacturers to make the drugs available to state health plans and Medicaid participants at pre-violation prices. The bill also includes provisions to protect confidential financial information provided by drug companies during investigations. The bill is set to take effect on January 1, 2024.

Committee Categories

Health and Social Services

Sponsors (77)

Dave Koehler (D)* Nabeela Syed (D)* Carol Ammons (D),  Jaime Andrade (D),  Dee Avelar (D),  Harry Benton (D),  Kam Buckner (D),  Kelly Burke (D),  Mary Beth Canty (D),  Jonathan Carroll (D),  Kelly Cassidy (D),  Cristina Castro (D),  Javier Cervantes (D),  Sharon Chung (D),  Lakesia Collins (D),  Terra Costa Howard (D),  William Davis (D),  Dan Didech (D),  Mary Edly-Allen (D),  Paul Faraci (D),  Laura Faver Dias (D),  Mary Flowers (D),  La Shawn Ford (D),  Suzy Glowiak Hilton (D),  Edgar González (D),  Will Guzzardi (D),  Mike Halpin (D),  Matt Hanson (D),  Sonya Harper (D),  Napoleon Harris (D),  Barbara Hernandez (D),  Norma Hernandez (D),  Maura Hirschauer (D),  Mattie Hunter (D),  Hoan Huynh (D),  Lilian Jiménez (D),  Adriane Johnson (D),  Gregg Johnson (D),  Emil Jones (D),  Stephanie Kifowit (D),  Jenn Ladisch Douglass (D),  Lindsey LaPointe (D),  Kimberly Lightford (D),  Camille Lilly (D),  Meg Loughran Cappel (D),  Theresa Mah (D),  Natalie Manley (D),  Joyce Mason (D),  Rita Mayfield (D),  Debbie Meyers-Martin (D),  Anna Moeller (D),  Bob Morgan (D),  Marty Moylan (D),  Laura Murphy (D),  Michelle Mussman (D),  Suzanne Ness (D),  Kevin Olickal (D),  Aarón Ortíz (D),  Mike Porfirio (D),  Willie Preston (D),  Abdelnasser Rashid (D),  Sue Rezin (R),  Bob Rita (D),  Sue Scherer (D),  Mike Simmons (D),  Justin Slaughter (D),  Steve Stadelman (D),  Anne Stava-Murray (D),  Doris Turner (D),  Dave Vella (D),  Rachel Ventura (D),  Celina Villanueva (D),  Mark Walker (D),  Chris Welch (D),  Maurice West (D),  Ann Williams (D),  Janet Yang Rohr (D), 

Last Action

Public Act . . . . . . . . . 103-0367 (on 07/28/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...